Irina DOTSENKO
7Patents
1h-index
14Co-inventors
40Inventor score
Filing activity: Jan 9, 2017 → Dec 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10376481B2 | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders | Human Necessities | 3 | Active |
| US10675353B2 | Pegylated carfilzomib compounds | Chemistry; Metallurgy | 1 | Active |
| US11242337B2 | Compounds useful for treating gastrointestinal tract disorders | Chemistry; Metallurgy | 1 | Active |
| US10517954B2 | Pegylated carfilzomib compounds | Chemistry; Metallurgy | 1 | Active |
| US11147884B2 | Inhibitors of NHE-mediated antiport | Chemistry; Metallurgy | 0 | Active |
| US11077198B2 | Pegylated carfilzomib compounds | Chemistry; Metallurgy | 0 | Active |
| US12281103B2 | Compounds useful for treating gastrointestinal tract disorders | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.